Overview
Arterial Disease
Risk Stratification in Atherosclerotic Carotid Stenosis
Carotid Ultrasound for Stroke Prediction (CUSP) Study
Vascular Biology of carotid plaque
Metabnomics of arterial tissue
Venous Disease
Pathogenesis of Varicose Veins
Endovenous Thermal Ablation of Varicose Veins
Development of an Engineered Valve for Deep Venous Reconstruction
Outcomes Research
Quality of Life Assessment and Cost effectiveness
Researchers
Miss Amanda Shepherd
Mr Ankur Thapar
Collaborations
Dr Claudia Monaco, Cytokine Biology of Atherosclerosis Group
Dr Ewa Paleolog, Cytokine Biology of Vessels Group
Professor Edward Leen, Imaging Science
Dr David Owen, Dr Vahitha Abdul-Salam and Dr Robert Edwards, Investigative Science
Professor Paulo Camici, Dr Oliver Gaemperli and Dr Ornella Rimoldi, Clinical Sciences Centre
Professor Xiao Yun Xu, Biofluid Mechanics
Dr Manuel Mayr and Dr Athanasios Didangelos, Vascular Proteomics, King’s College London
Dr Joseph Rafetto, Division of Vascular Surgery, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
Sources of Funding
- European Society for Vascular Surgery
- European Venous Forum
- Royal College of Surgeons of England
- Circulation Foundation
- Stroke Association
- Graham-Dixon Charitable Trust
- Peel Medical Research Trust
- Mason Medical Research Foundation
- Royal Society of Medicine UK Venous Forum
- Dunhill Medical Trust
- British Heart Foundation
Collaborators
Mr Manj Gohel, Cambridge University, Areterial and Venous Research, 2013
Dr Claudia Monaco. Professor M Feldmann, Oxford University, Vascular Biology, 2012
Joseph Rafetto,, Harvard, Venous Disease and research, 2010
Guest Lectures
Deep Venous Valve Reconstruction Is Underutilized, Veith Symposium, New York, 2013
Risk Of Intracerebral Aneurysm Rupture During CEA Or CAS, Veith Symposium, New York, 2013
What Is The Cost For Screening And Treating Patients With High Grade Carotid Stenosis: How Effective Is It In Preventing Strokes, Veith Symposium, New York, 2013
The NICE guidelines in the Management of Varicose Veins, Vascular Society of GBI, 2013
Vein Diameter Is A Poor Determinate By Which To Ration Varicose Vein Treatment, Veith Symposium, New York, 2013
Should We Treat Truncal Reflux And Varicose Veins All In One Session, Veith Symposium, New York, 2013
Are The NICE 2013 UK Guidelines On The Management Of Venous Disease The Same As The SVS/AVF, Veith Symposium, New York, 2013
Challenging configurations and elegant solutions in complex AAA repair, Dutch Vascular Society, 2013
Endovenous Treatments, XIV International Symposium of Angiology and Vascular Surgery, - Oporto/ Portugal, 2013
Glue is the Answer, UIP, Boston, 2013
European Phlebology, UIP, Boston, 2013
Cost effectiveness in the management of venous disease, UIP, Boston, 2013
Flow dynamics in the venous system, UIP, Boston, 2013
Chronic Venous disease diagnosis and treatment, European Venous Forum, Belgrade, 2013
C2 Disease: Insurance coverage in UK, International Vein Congress, Miami, 2013
Treatment options, Clinical Outcome (Quality of Life) & Cost Benefit, International Vein Congress, Miami, 2013
Are venous anomalies in MS patients relevant or not, International Vein Congress, Miami, 2013
Cost effectiveness in Management of Venous Disease, Venous Forum, 2013
Patterns of recurrence after treatment of superficial disease, Venous Symposium, New York, 2013
Clinical presentation and ultrasound findings: Their significance in Patient management., Venous Symposium, New York, 2013
Who should perform venous investigations, Venous Forum, 2013
Risk of AAA rupture, Indian Vascular Meeting, Bangalore, 2013
Cost effectiveness in VVV treatment, EVC, Masstricht, 2013
Patterns of SSV reflux, EVC, Masstricht, 2013
Diagnosis and investigation of Pelvic Congestion Syndrome, ISVS, Miami, 2013
Single treatment is the best option, ISVS, Miami, 2013
Early results of the eSCOPE Trial, American Venous Forum, Phoenix, 2013
Contrast ultrasound evaluation of texture of carotid plaque, Munich Vascular Symposium, 2012
CEA is stiil superior to CAS in patients with an irradiated neck, Munich Vascular Symposium, 2012
Neurological Complications Of Sclerotherapy For Varicose Veins: Incidence And Prevention, Veith Symposium, New York, 2012
We Should Stop Screening For Asymptomatic Carotid Stenosis Even Though There Is A Substantial Incidence Of Silent Cerebral Events In These Patients: What Should We Do About It, Veith Symposium, New York, 2012
Are Venous Anomalies In MS Patients Relevant Or Not, Veith Symposium, New York, 2012
Dynamic Contrast Ultrasonography To Stratify Risk In Asymptomatic Carotid Stenosis Patients: How Does It Work, Veith Symposium, New York, 2012
It Does Not Matter Which Device For Truncal Vein Ablation, The Results Are The Same, Veith Symposium, New York, 2012
Cost Analysis Of Carotid Interventions In Asymptomatic Patients, Veith Symposium, New York, 2012
C2 Venous Disease Is Progressive: Its Treatment Should Be A Covered Insurance Benefit, Veith Symposium, New York, 2012
Tumenecentless VV treatments, ESVS, Bologna, 2012
EVAR for difficult Anatomy., VISCON, India, 2012
CCSVI is there a role?, BSET, Warwickshire, 2012
Carotid endarterectomy is superior to CAS in the irradiated neck., Portugese Vascular and Angology Society, 2012
Costs in the management of venus disease, Portugese Vascular and Angology Society, 2012
PMT is the optimal treatment for DVT., Australian College of Phlebology, 2012
Perioperative instructions in the intervention of VV, Australian College of Phlebology, 2012
Ultrasound in CCSVI., Australian College of Phlebology, 2012
Editor’s choice., Australian College of Phlebology, 2012
Haemodynamics and quality of life., Australian College of Phlebology, 2012
Segmental disease in venoius disease., Australian College of Phlebology, 2012
Guidelines for the management of VV., Australian College of Phlebology, 2012
No single treatment modality fits all., Australian College of Phlebology, 2012
Which sclerosant is best?, Australian College of Phlebology, 2012
Glue is the treatment of VV., Australian College of Phlebology, 2012
Neurological complications after foam sclerotherapy, Australian College of Phlebology, 2012
It matters not a jot which endothermal technique you use., Charing Cross Symposium, London, 2012
CCSVI a real entity., Charing Cross Symposium, London, 2012
Deep vein reconstruction., Charing Cross Symposium, London, 2012
Management of C2 Disease., EVC, Mastaricht, 2012
Guidelines in management of VV., EVC, Mastaricht, 2012
Foam sclerotharapy is possible in all patients with varicose veins, AVF, Florida, 2012
Quality of life tools can be used to ration varicose vein treatment, CACVS, Paris, 2012
Foam sclerotherapy is not neurologically safe, CACVS, Paris, 2012
Minimally invasive management of VVs, Balkan Venous Forum, Belgrad, 2011
Foam and liquid sclerotherapy, Balkan Venous Forum, Belgrad, 2011
How I do endothermal ablation, Saudi Phlebological Conference, Riyadh, 2011
Radiofrequency ablation for VVs, Saudi Phlebological Conference, Riyadh, 2011
LeGoo for vessel occlusion., Veith, New York, 2011
Ascending and descending theories of VV., Veith, New York, 2011
Quality of life tools cannot be used as a rationing tool., Veith, New York, 2011
UK based Guidelines on the management of varicose veins, Veith, New York, 2011
Guidelines in the Management of VV., Saudi Phlebological Conference, Riyadh, 2011
Endovenous ablation is better than open surgery, Turkish Vascular Society/ESVS:, Antyla, 2011
How do we make sense of these different ablative techniques?, European Venous Forum, Vienna, 2011
Carotid endarterectomy is still the gold standard., Turkish Vascular Society/ESVS:, Antyla, 2011
Endovenous ablative techniques an update, ESVS, Athens., 2011
980nm Laser vs VNUS closure a comparison for ablation, Mediteranean Vein Symposium:, Nice, 2011
Infrainguinal arterial disease: Endovascular or surgery, LIVE meeting, Greece, 2011
Cost effectiveness: how to justify endothermal ablation, LIVE meeting, Greece, 2011
Clampless surgery in renal access., Charing Cross International Symposium, London, 2011
Outcomes in Venous Disease., Charing Cross International Symposium, London, 2011
Cost effectiveness its importance in venous disease, Venous Forum RSM, London, 2011
Ablation in the management of Venous Ulcers., Australasian College of Phlebology, Melbourne, 2011
Ascending vs Descending theory of Vein development, Australasian College of Phlebology, Melbourne, 2011
Foam sclerotherapy is it safe., Australasian College of Phlebology, Melbourne, 2011
Endothermal ablation pros and cons, Australasian College of Phlebology, Melbourne, 2011
Outcomes and assessment in venous disease, Australasian College of Phlebology, Melbourne, 2011
How not to burn as an author an editors view, Australasian College of Phlebology, Melbourne, 2011
Endothermal ablation; what would the patients think if asked., CACVS, Paris, 2011
Being a Professor of Surgery., SARS, Dublin, 2011
Endothermal ablation in 2010., Belgian Vascular Meeting, Leuven, 2010
Contrast ultrasound in carotid plaque evaluation., Veith Symposium, New York, 2010
Iliac artery disease in cyclist., Veith Symposium, New York, 2010
Is foam sclerotherapy safe?, Veith Symposium, New York, 2010
Concommitant phlebectomy is essential., Turkish Vascular Society, Antalya, 2010
Is foam sclerotherapy the answer to truncal veins, Turkish Vascular Society, Antalya, 2010
Endothermal ablation., European Vascular Society, Amsterdam, 2010
Statistics at the next level., European Venous Forum, Antwerp, 2010
Endovascular management of popliteal aneurysm., Portugese Vascular Society, Oporto, 2010
Endovenous thermal ablation., Portugese Vascular Society, Oporto, 2010
Duplex surveillance in lower limb reconstruction., LIVE meeting, Greece, 2010
Venous Outcomes., LIVE meeting, Greece, 2010
Medical management of PTS., Venous Forum, London, 2010
Foam sclerotherapy is Safe., Charing Cross Symposium, London, 2010
Ascending and descending theory., European Vascular Course, Masstaricht, 2010
Surgery in tertiary access., Charing Cross Symposium, London, 2010
Anti-platlet agents and CEA., CACVS, Paris, 2010
Quality of life in Venous Disease and Expert panel,, American College of Phlebology, Palm Springs California., 2009
Outcomes in Venous Disease,, American Venous Forum, Hawaii, 2009
Endothermal techniques in Venous Disease., Balkan Venous Forum, 2009
Evidence of endothermal ablation., Italian Phlebology:, Italy, 2009
Outcome evaluation in venous disease, UIP, Monaco, 2009
Scientific basis of papers and presentation :, Interanional European Venous Forum, Copenhagen, 2009
Endovenous ablation the facts!, International Arabic Vascular Society:, Saudi Arabia, 2009
EVAR in the high risk patient, International Arabic Vascular Society, Saudi Arabia, 2009
Carotid endarterectomy is the gold standard, International Arabic Vascular Society:, Saudi Arabia, 2009
Endothermal ablation summary of results., Charing Cross Symposium:, 2009
Sense or nonsense of follow up after conventional vascular surgery, Belgium Symposium, Leuven:, 2008
International Venous Registry ., American College of Phlebology, Florida:, 2008
Iliac compression effect on cyclists.:, Veith Symposium, New York, 2008
Lower limb ischaemia. . :, ESVS, Nice, 2008
International venous Registry, European Venous Forum, Barcelonna, 2008
How an editor handles and considers a submitted paper, Vascular symposium:, Larissa, 2008
Staged or combined management is preferable in patients with coronary artery disease and AAA? Has the application of endovascular treatment influenced the clinical practice?", Vascular symposium:, Larissa, 2008
International Venous Registry, Charing Cross Symposium, 2008
Multiple visits versus single.:, Charing Cross Symposium, 2008
Management of ischaemic leg. :, Diabetic Association, 2008
Management of leg ulcers., Turkish Wound Society, 2007
Supervised exercise a forgotten entity., Veith Symposium, New York, 2007
International Venous Registry ., Veith Symposium, New York, 2007
Cognitive effects of Carotid intervention., RSM, 2007
Laser Vein ablation:, Pros and Cons International Society of Vascular Surgery., Milan, 2007
International Venous Registry:, Serbian Phlebological Society, Belgrade, 2007
Vein Graft Surveillance, RSM, London, 2007
International Venous Registry:, European Society of Vascular Surgery, Madrid, 2007
Is EVAR the best treatment choice fof AAA., Larissa, Greece, 2007
International Venous Registry: : June 2007, European Venous Forum, Istanbul, 2007
Quality of life in venous disease., Galway, 2007
Complex Renal access. :, IV Renal Access Meeting, 2007
International Venous Registry :, Charing Cross Symposium, 2007
Methods of venous ablation, RSM, 2007
Open Surgery is still the best technique to ablate the great saphenous vein., Veith Symposium, New York, 2006
DVT Prophylaxis: a Cinderella?, Vascular symposium, Oporto, 2006
European Venous Registery., Vascular symposium, Oporto, 2006
Superfical venous surgery for venous ulceration, European Society for Vadcular surgery, Prague, 2006
Deep Vein Reconstruction, VSS/BVF meeting, London, 2006
Stenting for small AAA, Imperatives Course, Coventry:, 2006
Open surgery is the answer to varicose veins., Charing Cross Symposium, London, 2006
Oh Boy do I feel Old. Symposia on Long Saphenous Vein ablation, American Venous Forum, Miami, 2006
Management of the ischaemic complications of renal access, Veith Symposium, New York, 2005
This house believes that varicose vein surgery should be available on the NHS., Vascular Surgical Society, Bournemouth, 2005
Endovenous laser ablation, Vascular Symposium, Oporto, Portugal, 2005
The role of surgery in the management of leg ulcers, Vascular Symposium, OPorto, Portugal;, 2005
Management of difficult access, Renal Access Symposium, Amsterdam, 2005
Kippel Trenawny Syndrome, JVRG, 2005
Open Repair is the method of choice for ruptured Aortic Aneurysm Repair, Charing Cross Symposium, London, 2005
Numerous Guest Lectures on vascular disease on average 40 per annum, Worldwide
Cost effectiveness of VV treatment, Charing Cross International Symposium
Research Staff
Lane,TRA
Onida,S
Research Student Supervision
Lane,T, Varicose vein outcomes